September 25, 2026
Atavistik
Atavistik, a biotech company, raised a Series B extension earlier this year, bringing the total Series B to $160 million.
- Round
- Series B
- Amount raised
- $160M
- Lead investor
- —
- Industry
- Biotechnology
- Headquarters
- United States
- Employees
- 11-50 employees
- Website
- atavistikbio.com
- View profile →
Other investors
- RA Capital Management
- Regeneron